A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2011
11/15/2011	US8058235 Water-mediated control of depolymerization step of glatiramer acetate synthesis
11/15/2011	US8058234 Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease
11/15/2011	US8058233 Modification of feeding behavior using PYY and GLP-1
11/15/2011	US8058232 HMGB1 high affinity binding domain Box-A mutants
11/15/2011	US8058231 Transcriptional regulation of high affinity IgE receptor γ-chain
11/15/2011	US8058230 Neurotensin receptor agonists and opioid receptor agonists
11/15/2011	US8058229 Method of increasing red blood cell levels or treating anemia in a patient
11/15/2011	US8058228 Leptin peptide antagonists
11/15/2011	US8058227 Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD
11/15/2011	US8058226 a mixture of antihemophilic factor, bulking agent selected from mannitol, glycine and alanine, stabilizer agents selected from sucrose, trehalose, raffinose and arginine, calcium chloride, sodium chloride and buffers, having storage stability
11/15/2011	US8058066 Cellular factor-containing solution compositions
11/15/2011	US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
11/15/2011	US8058012 Five-helix protein
11/15/2011	US8057996 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
11/15/2011	US8057831 Actinidin
11/15/2011	US8057825 Krill extracts for treatment of cardiovascular diseases
11/15/2011	US8057822 Modified exendins and exendin agonists
11/15/2011	US8057810 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application
11/15/2011	US8057808 Use of a botulinum neurotoxin to alleviate various disorders
11/15/2011	US8057807 Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction
11/15/2011	US8057802 Treatment methods for fibrosis related disorders
11/15/2011	US8057801 Tick galectin
11/15/2011	US8057800 antiallergens; antibody for patient hypersensitive to peanuts or tree nuts; isolated peptide comprising an Ara h 2 T cell epitope; diagnosing or monitoring the allergenic condition in a mammal
11/15/2011	US8057799 ErbB interface peptidomimetics and methods of use thereof
11/15/2011	US8057792 Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus
11/15/2011	US8057787 Protease resistant modified interferon-beta polypeptides
11/15/2011	US8056719 Multipurpose packages for sterile products or products to be sterilized
11/15/2011	CA2624123C Glucagon-like peptide-1 secretagogue, glucagon-like peptide-1 secretagogue food or drink, inhibitor of postprandial rise in blood glucose, and inhibitory food or drink of postprandial rise in blood glucose
11/15/2011	CA2518295C Methods of inducing the expression of bone morphogenetic proteins (bmps) and transforming growth factor-.beta. proteins (tgf-.beta.s) in cells
11/15/2011	CA2450473C Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
11/15/2011	CA2421791C Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
11/15/2011	CA2418793C Pharmaceutical composition comprising an analgesic peptide
11/15/2011	CA2405715C Methods for selective targeting
11/15/2011	CA2392877C Improvements in or relating to immune responses to hiv
11/15/2011	CA2372929C Medicament for topical application
11/15/2011	CA2368772C Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
11/15/2011	CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2011	CA2352537C Tgf.beta.1-inhibitor peptides
11/15/2011	CA2343979C Human interleukin-b50, therapeutic uses
11/15/2011	CA2339879C Carbonyl-stress improving agent and peritoneal dialysate
11/15/2011	CA2303317C Product for promoting dural or meningeal tissue growth comprising collagen
11/15/2011	CA2267197C Isolation and use of motoneuronotrophic factors
11/15/2011	CA2257851C Modulators of tissue regeneration
11/15/2011	CA2189349C Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/15/2011	CA2170641C Senescent cell-derived inhibitors of dna synthesis
11/12/2011	CA2740237A1 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof
11/10/2011	WO2011140429A1 Delivery of cholesteryl ester to steroidogenic tissues
11/10/2011	WO2011140337A2 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
11/10/2011	WO2011140274A2 Method and device for transdermal delivery of parathyroid hormone using a microprojection array
11/10/2011	WO2011140267A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
11/10/2011	WO2011140266A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases
11/10/2011	WO2011140219A1 Biocatalysts for ezetimibe synthesis
11/10/2011	WO2011140176A1 Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection
11/10/2011	WO2011140135A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
11/10/2011	WO2011140132A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
11/10/2011	WO2011140092A1 Bifunctional molecules for inactivating hiv and blocking hiv
11/10/2011	WO2011140009A1 Methods of using semi-synthetic glycopeptides as antibacterial agents
11/10/2011	WO2011139992A1 Aromatic-cationic peptides and uses of same
11/10/2011	WO2011139988A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
11/10/2011	WO2011139986A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
11/10/2011	WO2011139907A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
11/10/2011	WO2011139881A2 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses
11/10/2011	WO2011139854A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
11/10/2011	WO2011139853A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
11/10/2011	WO2011139838A2 Intranasal formulations
11/10/2011	WO2011139820A1 Methods of use of soluble cd24 for therapy of rheumatoid arthritis
11/10/2011	WO2011139819A2 Creation of oxidation-resistant hdl mimetic peptides
11/10/2011	WO2011139801A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
11/10/2011	WO2011139799A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
11/10/2011	WO2011139769A2 Immunogenic compositions and methods for treating neoplasia
11/10/2011	WO2011139738A2 Therapies using zanolimumab to enhance the immune response
11/10/2011	WO2011139714A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
11/10/2011	WO2011139672A1 Antimicrobial bacteria strains and uses thereof
11/10/2011	WO2011139488A2 Methods and materials for reducing cardiac xenograft rejection
11/10/2011	WO2011139391A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
11/10/2011	WO2011139370A1 Therapeutic peptide composition and method
11/10/2011	WO2011139349A1 Compositions for linking zinc finger modules
11/10/2011	WO2011139237A1 Composition for the treatment of helicobacter pylori (h. pylori) infectious
11/10/2011	WO2011139226A1 Compounds, medicaments and methods of treatment for helicobacter pylori infection.
11/10/2011	WO2011138977A1 Method of preventing or treating body weight-related disorders by employing vaspin
11/10/2011	WO2011138842A1 Therapeutic agent for rheumatoid arthritis
11/10/2011	WO2011138802A1 Injection solution
11/10/2011	WO2011138785A2 Use of ccl1 in therapy
11/10/2011	WO2011138565A1 Pharmaceutical combination containing lipoic acid, hydroxycitric acid and a somatostatin as active ingredients
11/10/2011	WO2011138489A1 Use of casein hydrolysates as antiviral agents
11/10/2011	WO2011138449A2 Antagonists of sema3e/plexind1 interaction as anti-cancer agents
11/10/2011	WO2011138421A1 Combination therapy
11/10/2011	WO2011137886A1 Agents for treating alzheimer's disease
11/10/2011	WO2011137540A1 Gfi1b modulation and uses thereof
11/10/2011	WO2011120013A9 Vista regulatory t cell mediator protein, vista binding agents and use thereof
11/10/2011	WO2011113942A3 Method for predicting the responsiveness to chemotherapy
11/10/2011	WO2011113819A3 Diagnosis and treatment of cancer based on avl9
11/10/2011	WO2011104708A3 Methods for inhibiting necrosis
11/10/2011	WO2011087795A3 Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases
11/10/2011	WO2011085081A3 Methods of selecting ms patients for antigen specific therapy
11/10/2011	WO2011084967A3 Methods and compositions for providing protective immunity in the elderly
11/10/2011	WO2011073918A3 Peptides as modulators of fprl1 and/or fprl2
11/10/2011	WO2011072288A3 Insulin analogues with chlorinated amino acids
11/10/2011	WO2011066369A9 Antagonists of il-6 to raise albumin and/or lower crp

1 ... 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 ... 3163